Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Lisa Sanford

Corrigendum to “A Randomised Trial of Fluticasone Furoate/Vilanterol (50/25 Μg; 100/25 Μg) on Lung Function in COPD” [Respir Med, 107 (2013) 560–569]

Respiratory Medicine

Pulmonary

Respiratory Medicine

2013

English

A Randomised Trial of Fluticasone Furoate/Vilanterol (50/25 Μg; 100/25 Μg) on Lung Function in COPD

English

Related publications

Corrigendum to “Fluticasone Furoate/Vilanterol (100/25; 200/25 Μg) Improves Lung Function in COPD: A Randomised Trial” [Respir Med 107 (2013) 550–559]

English

Efficacy and Safety of Fluticasone Furoate 100 Μg Once-Daily in Patients With Persistent Asthma: A 24-Week Placebo and Active-Controlled Randomised Trial

English

Safety and Efficacy of Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism Randomly Assigned to Receive Fixed 25-Μg or 50-Μg Daily Doses

Clinical Therapeutics

Pharmacology

2017

English

Reduction in All-Cause Mortality With Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients

American Journal of Respiratory and Critical Care Medicine

Pulmonary

Critical Care

Respiratory Medicine

Intensive Care Medicine

2020

English

Uterotonics in Elective Caesarean Delivery: A Randomised Non-Inferiority Study Comparing Carbetocin 20 Μg and 100 Μg

English

PERBANDINGAN EFEKTIVITAS MISOPROSTOL DOSIS 50 Μg DAN 100 Μg TERHADAP KEBERHASILAN KELAHIRAN INDUKSI DI RSU PKU MUHAMMADIYAH YOGYAKARTA

Pharmaciana

2014

English

A Comparison of the Efficacy and Safety of Once-Daily Fluticasone Furoate/Vilanterol With Twice-Daily Fluticasone Propionate/Salmeterol in Moderate to Very Severe COPD

European Respiratory Journal

English

INSTEAD: A Randomised Switch Trial of Indacaterolversussalmeterol/Fluticasone in Moderate COPD

European Respiratory Journal

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Lisa Sanford

Corrigendum to “A Randomised Trial of Fluticasone Furoate/Vilanterol (50/25 Μg; 100/25 Μg) on Lung Function in COPD” [Respir Med, 107 (2013) 560–569]

A Randomised Trial of Fluticasone Furoate/Vilanterol (50/25 Μg; 100/25 Μg) on Lung Function in COPD

Related publications

Corrigendum to “Fluticasone Furoate/Vilanterol (100/25; 200/25 Μg) Improves Lung Function in COPD: A Randomised Trial” [Respir Med 107 (2013) 550–559]

Efficacy and Safety of Fluticasone Furoate 100 Μg Once-Daily in Patients With Persistent Asthma: A 24-Week Placebo and Active-Controlled Randomised Trial

Safety and Efficacy of Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism Randomly Assigned to Receive Fixed 25-Μg or 50-Μg Daily Doses

Reduction in All-Cause Mortality With Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients

Uterotonics in Elective Caesarean Delivery: A Randomised Non-Inferiority Study Comparing Carbetocin 20 Μg and 100 Μg

PERBANDINGAN EFEKTIVITAS MISOPROSTOL DOSIS 50 Μg DAN 100 Μg TERHADAP KEBERHASILAN KELAHIRAN INDUKSI DI RSU PKU MUHAMMADIYAH YOGYAKARTA

A Comparison of the Efficacy and Safety of Once-Daily Fluticasone Furoate/Vilanterol With Twice-Daily Fluticasone Propionate/Salmeterol in Moderate to Very Severe COPD

INSTEAD: A Randomised Switch Trial of Indacaterolversussalmeterol/Fluticasone in Moderate COPD